The overall purpose of DEXLIFE is to identify novel diagnostic and predictive biomarkers
- Which can more effectively detect the progression toward diabetes in high risk individuals
- Which are responsive to lifestyle interventions known to be effective in the prevention of diabetes
The results obtained within DEXLIFE are summarised in the handbook below.
EU FP7 programme
Grant agreement no: 279228
Project Full Title: Mechanisms of prevention of type 2 diabetes by lifestyle intervention in subjects with pre-diabetes or at high risk for progression.
Total budget: 7,6 mio Euros
EU contribution: 5,5 mio Euros